James Blachly: Clinical Trials

1 trial sponsored by James Blachly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow James Blachly: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
sotrastaurin acetate, pharmacological study, laboratory biomarker analysis - Prolymphocytic Leukemia, Recurrent Mantle Cell Lymphoma
Phase 2WithdrawnJames Blachly2015-03-122017-04-05

Conditions studied

Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Prolymphocytic (1)  ·  Lymphoma, Mantle-Cell (1)

Interventions

sotrastaurin (1)